AzTrials
AzTrials

StressNCT04780113

Evolution of Perceived Stress in General Practice Residents During COVID-19 Sanitary Crisis

An observational study of Stress, run by Centre Hospitalier Eure-Seine at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Over the last several years, distress among healthcare professionals is well described, and general practice residents are also affected. Because of COVID-19 sanitary crisis, stress factors are increased, and that may cause anxiety, exhaustion, psychic distress, depression, addictions, or post traumatic stress. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Stress
How many people
185 participants
Where
1 siteFrance
Study dates
25 Feb 2021to 24 Sep 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Participants being general practice residents in Caen or Rouen

Who may be able to join

  • Being a general practice resident in Rouen or Caen
  • Participant informed and non-objection of him/her

Who cannot join

  • Being on maternity leave or not working during the period concerned with the questionnaires

Trial locations and contacts

1 site in 1 country.

France1 site
  • CH Eure-Seine

    Évreux, 27015

Other trials in France

About this study

Official title: Evaluation of Evolution of Perceived Stress in General Practice Residents of Rouen and Caen During COVID-19 Sanitary Crisis

Over the last several years, distress among healthcare professionals is well described, and general practice residents are also affected. Because of COVID-19 sanitary crisis, stress factors are increased, and that may cause anxiety, exhaustion, psychic distress, depression, addictions, or post traumatic stress.

Read the detailed description

This prospective non-interventional study aims to evaluate via two questionnaires the evolution of perceived stress in general practice residents of two centres in France, Rouen and Caen. The two questionnaires contain the Perceived Stress Scale, as well as items regarding socio-demographic data and stress factors. The first questionnaire is to be distributed during the epidemic COVID-19 wave and the second questionnaire at the end of the epidemic COVID-19 wave.

Conditions
Stress

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evolution of perceived stress during the epidemic wave of COVID19 vs. at the end of the epidemic wave of COVID19

    The perceived stress will be evaluated using the Perceived Stress Scale. This scale contains 10 items, with scores ranging from 0 to 40, with higher scores meaning a higher level of stress.

    Measured: maximum 6 months, according to the evolution of the epidemic

Secondary outcomes (2)
  1. Description of general characteristics of residents and their feelings and experiences with the sanitary crisis

    This include socio-demographic characteristics, work-related information and potential stress factors

    Measured: maximum 6 months, according to the evolution of the epidemic

  2. Assessment of residents' profile stress according to their socio-demographic and working characteristics

    Identification of stress factors among residents

    Measured: maximum 6 months, according to the evolution of the epidemic

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2021
  2. Study start25 Feb 2021
  3. Primary completion24 Sep 2021
  4. Study completion24 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
185 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04780113
Sponsor's protocol ID
2020-A03283-36
Other IDs
CHES N°20/01
Status last verified
Apr 2022
First submitted
1 Mar 2021
Last updated
22 Apr 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stress, run by Centre Hospitalier Eure-Seine at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evolution of perceived stress during the epidemic wave of COVID19 vs. at the end of the epidemic wave of COVID19 (time frame: maximum 6 months, according to the evolution of the epidemic). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in